Pursuant to Section 307B.4, Title 25, Oklahoma Statutes, consider convening in executive session to discuss an action relating to litigation against the manufacturers and distributors of opioids in an effort to hold them accountable for their marketing practices alleged to have caused public nuisance and monetary damages suffered by municipalities, specifically, the City’s pending litigation in City of Lawton v. Purdue Pharma Inc., et al, CIV-19-78 as part of In Re: National Prescription Opiate Litigation MDL No. 2804, to include a discussion and consideration for approval a potential settlement with Mallinckrodt PLC & Mallinckrodt LLC, and if necessary take action in open session that may include the approval one or more resolutions and/or other documents related to any such settlement.

Committee

City Council

Introduced

August 3, 2022

On agenda

August 9, 2022